- Research Use Only
- All products currently listed on this site are for research purposes ONLY
- Research Use Only
- All products currently listed on this site are for research purposes ONLY
- Research Use Only
- All products currently listed on this site are for research purposes ONLY
- Research Use Only
- All products currently listed on this site are for research purposes ONLY
In Stock
Pack of 10
Single Vial
Reta
10mg
15mg
30mg
Research Use Only
All products sold on this website are intended for research and identification purposes only and are not intended for human dosing, injections, or ingestion. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for legitimate laboratory research and not for human or animal consumption.
What is
Reta
?
Reta
Reta, also known as Retatrutide, is an investigational peptide studied for its interaction with GLP-1, GIP, and glucagon receptors at the cellular level. Research explores its effects on metabolic signaling, insulin sensitivity pathways, and energy regulation mechanisms in vitro.
Purity Reports
10mg
15mg
30mg
Certificate of Analysis
Frequently asked questions
Does the product come with instructions?
Products from Direct Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
What's the actual amount in each vial?
Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.
Are additional supplies needed?
Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
How long does a vial last?
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.
Need Help?
Send us a message.
Reta Overview
Reta, also known as Retatrutide, is a synthetic investigational peptide developed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is currently being studied for its potential effects on weight management, glucose regulation, and metabolic health in preclinical and clinical research models. By activating multiple incretin and glucagon receptors, Retatrutide demonstrates broad systemic effects that are under investigation for their relevance in metabolic and endocrine research.
Reta History
The development of Reta, also known as Retatrutide, builds on decades of research into incretin-based therapies for metabolic disorders. Early studies with GLP-1 receptor agonists established their role in glucose homeostasis and appetite regulation. Subsequent research expanded to dual agonists like tirzepatide (GLP-1/GIP), paving the way for Retatrutide, which uniquely integrates GLP-1, GIP, and glucagon receptor activity. This multi-agonist design reflects a new direction in peptide therapeutics aimed at investigating more comprehensive metabolic modulation in laboratory and clinical settings.
Reta Structure
CAS #: 2381089-83-2
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4845.44 g/mol
PubChem ID: 474492335
Reta Research Findings
Reta, also known as Retatrutide, has been examined in metabolic and systemic models, with studies highlighting its influence on glucose regulation, insulin signaling, lipid metabolism, and integrated hormone pathways. Research also points to its role in energy balance and multi-system signaling in preclinical and laboratory settings.
Key Areas of Research:
• Metabolic: Glucose, insulin, energy regulation
• Endocrine: GLP-1, GIP, glucagon pathways
• Cardiovascular: Lipid, cholesterol, hepatic signaling
• Systemic: Multi-hormone signaling, resilience, balance
Together, these findings suggest broad experimental potential for Retatrutide across metabolic, cardiovascular, and systemic models. By engaging multiple hormone pathways, it provides a versatile research platform for studying energy regulation, lipid metabolism, and integrated signaling across diverse biological systems.
Jastreboff A.M. et al., New England Journal of Medicine, 2023
